Medical device and MedTech insights, news, tips and more
FDA Releases Plan to Modernize the 510(k) Pathway
November 27, 2018
The FDA today released plans for updating its 510(k) clearance pathway, including a push to move away from using predicate devices over 10 years old and the creation of a new alternative 510(k) pathway that will allow approval based on objective safety and performance criteria.
In an official posting, FDA head Dr. Scott Gottliebb and FDA Center for Devices and Radiological Health head Dr. Jeff Shuren laid out plans the agency has for “modernizing” its 510(k) clearance pathway.
The release builds upon a strategy the federal watchdog laid out last week intended to improve overall post-market medical device oversight and to make the FDA “consistently first among the world’s regulatory agencies to identify and act upon safety signals related to medical devices.”
In their update, the FDA heads said they “believe firmly in the merits of the 510(k) process,” but that they believe the system must be modernized to “reflect advances in technology, safety and the capabilities of a new generation of medical devices.”
“The 510(k) pathway represents a more contemporary approach to the risk-based regulation of medical products, but this doesn’t mean the pathway is perfect or not in need of change,” FDA heads Gottlieb and Shuren wrote in the release.
The first major change announced for the regulatory pathway is promoting the use of modern predicates for approvals to be based upon, according to the release.
“Nearly 20% of current 510(k)s are cleared based on a predicate that’s more than 10 years old,” FDA heads wrote in the posting.
The FDA went on to say that it is considering making devices that demonstrated substantial equivalence based on older predicate devices public on the CDRH website, focusing on those based on devices 10 years or older.
“Our goal in focusing on older predicates is to drive sponsors to continually offer patients devices with the latest improvements and advances,” FDA heads wrote.
The agency clarified that it doesn’t believe devices more than 10 years old are unsafe, or that such devices would need to be removed from the market, but that it is looking to encourage developers to use more modern predicates. Such a push, the agency hopes, will improve competition to adopt modern features and increase selection choice between old and newer devices while improving overall standards and improving outcomes.
Other efforts include a potential “sunset” to older predicates to promote the use of more modern devices for comparison, the FDA said in its release.
Moving away from issues with older predicate devices, the FDA said that, beginning next year, it intends to finalize guidelines which would create an alternative 510(k) pathway that would allow producers of well-known device types to demonstrate substantial equivalence through objective safety and performance criteria, saying that they “believe this approach is the future of the 510(k) program.”
“Rather than looking to the past as a baseline for safety and effectiveness – and rely on predicate devices that are sometimes decades old as our point of comparison – our premarket review would be based on a contemporary baseline that looks to the future and a baseline that can be updated as technologies advance,” FDA heads wrote.
Through the new route, dubbed the “Safety and Performance Based Pathway,” a company would only have to demonstrate that their device meets performance-based criteria that the FDA has set to achieve approval, according to the release. The criteria would be based upon the safety and performance of modern predicate devices, the agency added.
Read More at the Source: FDA releases 510(k) modernization plans – MassDevice
Written by: Fink Densford
A Speciality Recruiting Firm Exclusively Servicing The Medical Device Industry
Legacy MedSearch has more than 30 years of combined experience recruiting in the medical device industry. We pride ourselves on our professionalism and ability to communicate quickly and honestly with all parties in the hiring process. Our clients include both blue-chip companies and innovative startups within the MedTech space. Over the past 10 years, we have built one of the strongest networks of device professionals ranging from sales, marketing, research & , quality & regulatory, project management, field service, and clinical affairs.
We offer a variety of different solutions for hiring managers depending on the scope and scale of each individual search. We craft a personalized solution for each client and position with a focus on attracting the best possible talent in the shortest possible time frame.
Are you hiring?
Contact us to discuss partnering with Legacy MedSearch on your position.